Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

Bristol-Myers Squibb (BMS) building

BMS exits hep C, diabetes and neuroscience drug discovery

Will discontinue 'broad-based discovery work' in the therapy areas

- PMLiVE

Bayer veteran joins Aurinia as CEO

Stephen Zaruby spent 20 years at German pharma company

Bayer symbol

Bayer files Eylea for diabetes complication in EU

Looks to keep with Novartis’ Lucentis

- PMLiVE

Ariad cuts 160 jobs in US after Iclusig suspension

Feels effect of FDA decision to suspend cancer drug on safety concerns

- PMLiVE

Salix boosts GI portfolio with $2.6bn deal for Santarus

Will reduce company’s reliance on diarrhoea treatment Xifaxan

Shire Basingstoke

Shire mulls UK job cuts

Enters “employee consultation process” for research site in Basingstoke

- PMLiVE

IDF appoints new CEO

Petra Wilson to head global diabetes organisation

- PMLiVE

Forecasting: Overcoming the pitfalls

You’ll never have perfect data all the time, but good forecasts can still be a powerful management tool

- PMLiVE

Medtronic and Lilly back JDRF’s diabetes walk

National sponsors of charity’s Walk to Cure Diabetes

- PMLiVE

Pfizer slams UK drug pricing plan

BioIndustry Association 
also challenges revision to PPRS

- PMLiVE

Profits down at Lundbeck as revenues slip

Company still feeling effects of Lexapro patent loss

- PMLiVE

EMA on track with biosimilars guidance says industry

Updates expected to build confidence among healthcare professionals and patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links